Cargando…
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus
Lipoprotein(a) (Lp(a)) is one of the strongest causal risk factors of atherosclerotic disease. It is rich in cholesteryl ester and composed of apolipoprotein B and apo(a). Plasma Lp(a) levels are determined by apo(a) transcriptional activity driven by a direct repeat (DR) response element in the apo...
Autores principales: | Kostner, Karam M., Kostner, Gerhard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998850/ https://www.ncbi.nlm.nih.gov/pubmed/35408941 http://dx.doi.org/10.3390/ijms23073584 |
Ejemplares similares
-
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
por: Enkhmaa, Byambaa, et al.
Publicado: (2020) -
Current Management and Future Perspectives in the Treatment of Lp(a) with a Focus on the Prevention of Cardiovascular Diseases
por: Farina, Juan M., et al.
Publicado: (2023) -
Editorial Lp(a) – the underestimated cardiovascular risk factor
por: Mellwig, Klaus-Peter
Publicado: (2017) -
Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013) -
Lp(a): When and how to measure it
por: Cegla, Jaimini, et al.
Publicado: (2020)